These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12043408)

  • 1. [Bacteremia and meningitis caused by Streptococcus pneumoniae during treatment with azithromycin].
    Lisby JG; Brasholt M; Teglbjoerg LL
    Ugeskr Laeger; 2002 May; 164(20):2629. PubMed ID: 12043408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteremia and meningitis caused by a macrolide-sensitive strain of Streptococcus pneumoniae during treatment with azithromycin.
    Lisby G; Brasholt MS; Teglbjerg MS
    Clin Infect Dis; 2001 Aug; 33(3):415-6. PubMed ID: 11438918
    [No Abstract]   [Full Text] [Related]  

  • 3. Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin.
    Kelley MA; Weber DJ; Gilligan P; Cohen MS
    Clin Infect Dis; 2000 Oct; 31(4):1008-11. PubMed ID: 11049784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled study.
    Schentag JJ; Klugman KP; Yu VL; Adelman MH; Wilton GJ; Chiou CC; Patel M; Lavin B; Paladino JA
    Int J Antimicrob Agents; 2007 Sep; 30(3):264-9. PubMed ID: 17587549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of macrolide resistance in Streptococcus pneumoniae.
    Nuermberger EL; Bishai WR
    J Antimicrob Chemother; 2003 Sep; 52(3):524-5; author reply 525. PubMed ID: 12888594
    [No Abstract]   [Full Text] [Related]  

  • 6. Macrolide and ketolide resistance with Streptococcus pneumoniae.
    Doern GV
    Med Clin North Am; 2006 Nov; 90(6):1109-24. PubMed ID: 17116439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae.
    Bergman M; Huikko S; Huovinen P; Paakkari P; Seppälä H;
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3646-50. PubMed ID: 16940064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breakthrough sepsis in macrolide-resistant pneumococcal infection.
    Jackson MA; Burry VF; Olson LC; Duthie SE; Kearns GL
    Pediatr Infect Dis J; 1996 Nov; 15(11):1049-51. PubMed ID: 8933560
    [No Abstract]   [Full Text] [Related]  

  • 9. Serious bacterial infection in children.
    Bergus G
    J Fam Pract; 1997 Jun; 44(6):531-2. PubMed ID: 9191620
    [No Abstract]   [Full Text] [Related]  

  • 10. Austrian syndrome caused by highly penicillin-resistant Streptococcus pneumoniae.
    Muñoz P; Sainz J; Rodríguez-Creixéms M; Santos J; Alcalá L; Bouza E
    Clin Infect Dis; 1999 Dec; 29(6):1591-2. PubMed ID: 10585831
    [No Abstract]   [Full Text] [Related]  

  • 11. Inferring the potential success of pneumococcal vaccination in Italy: serotypes and antibiotic resistance of Streptococcus pneumoniae isolates from invasive diseases.
    Pantosti A; Boccia D; D'Ambrosio F; Recchia S; Orefici G; Moro ML; ;
    Microb Drug Resist; 2003; 9 Suppl 1():S61-8. PubMed ID: 14633369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial-resistant Streptococcus pneumoniae: trends and management.
    Jacobs MR
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):619-35. PubMed ID: 18847402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new twist on an old problem. A case of pediatric meningitis caused by multidrug-resistant Streptococcus pneumoniae serotype 19 A.
    Ciccotelli WA; Poutanen SM; Alqahtani M; Morris SK; Cox P; Low DE; Pillai DR; Opavsky MA
    Pediatr Infect Dis J; 2009 Jan; 28(1):74-5. PubMed ID: 19057453
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations.
    Zhanel GG; DeCorby M; Noreddin A; Mendoza C; Cumming A; Nichol K; Wierzbowski A; Hoban DJ
    J Antimicrob Chemother; 2003 Jul; 52(1):83-8. PubMed ID: 12775677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breakthrough pneumococcal meningitis in a patient treated with pristinamycin.
    Goldstein F; Jonte J; Mandel F; Ben Ali A
    Clin Microbiol Infect; 2006 Jul; 12(7):696-7. PubMed ID: 16774574
    [No Abstract]   [Full Text] [Related]  

  • 16. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
    Ross JJ; Worthington MG; Gorbach SL
    N Engl J Med; 2002 Jul; 347(1):65-7; author reply 65-7. PubMed ID: 12097545
    [No Abstract]   [Full Text] [Related]  

  • 17. Change in pneumococcal susceptibility to azithromycin during treatment for acute otitis media.
    Toltzis P; Dul M; Blumer J
    Pediatr Infect Dis J; 2007 Jul; 26(7):647-9. PubMed ID: 17596812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.
    Mason EO; Wald ER; Bradley JS; Barson WJ; Kaplan SL;
    Pediatr Infect Dis J; 2003 Jul; 22(7):623-7. PubMed ID: 12867838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae.
    Lonks JR; Garau J; Gomez L; Xercavins M; Ochoa de Echagüen A; Gareen IF; Reiss PT; Medeiros AA
    Clin Infect Dis; 2002 Sep; 35(5):556-64. PubMed ID: 12173129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution.
    Saha SK; Naheed A; El Arifeen S; Islam M; Al-Emran H; Amin R; Fatima K; Brooks WA; Breiman RF; Sack DA; Luby SP;
    Clin Infect Dis; 2009 Mar; 48 Suppl 2():S75-81. PubMed ID: 19191622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.